1988
DOI: 10.1016/s0028-2243(88)80025-x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1990
1990
1997
1997

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 58 publications
0
1
0
Order By: Relevance
“…To date, over 40 monoclonal antibodies against ovarian tumour‐associated antigens have been reported 8 . It is therefore important to know if serum concentrations of other tumour markers may predict prognosis.…”
Section: Introductionmentioning
confidence: 99%
“…To date, over 40 monoclonal antibodies against ovarian tumour‐associated antigens have been reported 8 . It is therefore important to know if serum concentrations of other tumour markers may predict prognosis.…”
Section: Introductionmentioning
confidence: 99%